Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Metzger

Showing results (411-420 of 415) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 415 results.
Bioorganic & Medicinal Chemistry Letters|March 12, 2010
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityJian Liu, Shuwen He, Tianying Jian, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chiralityPing Liu, Thomas J Lanza, Marc Chioda, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligandsQingmei Hong, Raman K Bakshi, James Dellureficio, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2005
Discovery and activity of (1R,4S,6R)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-2-methyl-2-azabicyclo[2.2.2]octane-6-carboxamide (3, RY764), a potent and selective melanocortin subtype-4 receptor agonistZhixiong Ye, Liangqin Guo, Khaled J Barakat, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonistsShuwen He, Peter H Dobbelaar, Jian Liu, et al.
Pageof 42

Showing results (411-420 of 415) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 415 results.
Bioorganic & Medicinal Chemistry Letters|March 12, 2010
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityJian Liu, Shuwen He, Tianying Jian, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chiralityPing Liu, Thomas J Lanza, Marc Chioda, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligandsQingmei Hong, Raman K Bakshi, James Dellureficio, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2005
Discovery and activity of (1R,4S,6R)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-2-methyl-2-azabicyclo[2.2.2]octane-6-carboxamide (3, RY764), a potent and selective melanocortin subtype-4 receptor agonistZhixiong Ye, Liangqin Guo, Khaled J Barakat, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonistsShuwen He, Peter H Dobbelaar, Jian Liu, et al.
Pageof 42